Related references
Note: Only part of the references are listed.Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation
Ajit P. Limaye et al.
CLINICAL MICROBIOLOGY REVIEWS (2021)
Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance
Sunwen Chou
ANTIVIRAL RESEARCH (2020)
The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease
Islam T. M. Hussein et al.
ANTIVIRAL RESEARCH (2020)
Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection
Sunwen Chou et al.
ANTIVIRAL RESEARCH (2019)
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2018)
Cytomegalovirus antiviral resistance: characterization of results from clinical specimens
S. Kleiboeker et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Cytomegalovirus UL97 Kinase Catalytic Domain Mutations That Confer Multidrug Resistance
Sunwen Chou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo
Sunwen Chou et al.
ANTIVIRAL RESEARCH (2012)
Cytomegalovirus UL97 kinase mutations that confer maribavir resistance
Sunwen Chou et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action
KK Biron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
